Neutraciaa Lifesciences Private Limited, a active private limited company, was established on 11 February 2016 in Siliguri, West Bengal, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100WB2016PTC209725. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.18 M.
It upholds a compliant status. Employing 29 professional, Its leadership includes Indrakshi Basu (Director), Bipradas Mitra (Director), Tirthankar Pal (Director). Past directors included Debasis Roy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Keshabalayeastvivekanandapallyrajarammohanroyroad, Siliguri, West Bengal, 734006.
U24100WB2016PTC209725
209725
11 February 2016
₹3.00 M
₹2.18 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Neutraciaa Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indrakshi Basu | Director | 18 Jun 2016 | Current |
| Bipradas Mitra | Director | 18 Jun 2016 | Current |
| Tirthankar Pal | Director | 11 Feb 2016 | Current |
| Partha Sarathi Dutta | Director | 11 Feb 2016 | Current |
| Arindam Guha | Director | 11 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jan 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neutraciaa Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.86% increase. The company also saw a substantial improvement in profitability, with a 43.7% increase in profit. The company's net worth Soared by an impressive increase of 38.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Neutraciaa Lifesciences had a promoter holding of 47.50% and a public holding of 52.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Neutraciaa Lifesciences has a workforce of 29 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neutraciaa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neutraciaa Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Neutraciaa Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Neutraciaa Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Indrakshi Basu was appointed as a Director was appointed as a Director on 18 Jun 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
The activity Bipradas Mitra was appointed as a Director was appointed as a Director on 18 Jun 2016 & has been associated with this company since 9 years 6 months . was completed.
The activity Tirthankar Pal was appointed as a Director was appointed as a Director on 11 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
Progress on Partha Sarathi Dutta was appointed as a Director was appointed as a Director on 11 Feb 2016 & has been associated with this company since 9 years 10 months . was documented.
The CIN of Neutraciaa Lifesciences Private Limited is U24100WB2016PTC209725.
Neutraciaa Lifesciences Private Limited is headquartered at Keshabalayeastvivekanandapallyrajarammohanroyroad, Siliguri, West Bengal, 734006.
Neutraciaa Lifesciences Private Limited was incorporated on 11 February 2016.
The current directors of Neutraciaa Lifesciences Private Limited are
The primary industry of Neutraciaa Lifesciences Private Limited is Trade.
Neutraciaa Lifesciences Private Limited is unlisted.
The authorized capital of Neutraciaa Lifesciences Private Limited is ₹3.00 M, and the paid-up capital is ₹2.18 M.
The compliance status of Neutraciaa Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX